ArticleFrontiers in public health2024
Association between cardiovascular health and human papillomavirus infection: analysis from NHANES 2005-2016.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Sex and organ-specific risk and temporal trends of human papillomavirus-associated anogenital cancer among solid organ transplant recipients in the United States.International journal of cancer · 2026Article
- Human papillomavirus infection and atherosclerotic cardiovascular disease: a comprehensive review of epidemiological evidence, molecular mechanisms, and vaccination-mediated protection.Frontiers in genetics · 2026Review
- Exploring the potential link between human papillomavirus infection and coronary artery disease: a review of shared pathways and mechanisms.Molecular and cellular biochemistry · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Given the strong association between cardiovascular disease and human papillomavirus (HPV) infection, this study aimed to assess the correlation between HPV infection and cardiovascular health (CVH) as represented by the Life's Essential 8 (LE8) score. Methods: This study employed analysis of data obtained from the National Health and Nutrition Examination Survey covering the period from 2005 to 2016. To examine the correlation between the CVH score and both HPV and high-risk HPV (HR-HPV) infections, this research utilized a combination of multivariable regression analysis, smooth curve fitting, and subgroup analysis, following adjustment for pertinent covariates. Results: This study included a total of 8,264 women, with an average age of 39.53 ± 11.24 years. The HPV prevalence was 43.43% overall, while the HR-HPV prevalence was 17.36%. In the fully adjusted model, an augmentation of 10 points in the CVH score correlated with an 8% reduction in the HPV infection rate [0.92 (0.88-0.96)], and a similar 8% decrease in the HR-HPV infection rate [0.92 (0.87-0.97)]. Conclusion: Our findings indicate that elevated CVH, as denoted by higher LE8 scores, correlates with a decreased of HPV infection rate among U.S. females. The LE8 score shows potential as a shared predictive biomarker for both CVH and HPV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.